HBC Financial Services’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$2K Hold
50
﹤0.01% 158
2024
Q3
$2K Buy
+50
New +$2.35K ﹤0.01% 157
2021
Q2
Sell
-200
Closed -$12.8K 174
2021
Q1
$12.8K Sell
200
-600
-75% -$37.3K 0.01% 125
2020
Q4
$49K Buy
800
+186
+30% +$11.4K 0.04% 66
2020
Q3
$39K Sell
614
-186
-23% -$11.2K 0.03% 69
2020
Q2
$47K Buy
800
+500
+167% +$29.9K 0.04% 61
2020
Q1
$16K Buy
300
+50
+20% +$3.06K 0.02% 94
2019
Q4
$16K Buy
+250
New +$14.3K 0.01% 117

Other funds holding BMY

HBC Financial Services's BMY Position: Q4 2024 in Review

HBC Financial Services held its Bristol-Myers Squibb (BMY) position steady in Q4 2024 at 50 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #158.

HBC Financial Services first reported a position in BMY in Q4 2019 and has held it in 8 quarters since. The position peaked at $49K in Q4 2020. 2,493 funds tracked by Wall St. Rank hold BMY as of Q4 2024.

  • HBC Financial Services held 50 shares of Bristol-Myers Squibb worth $2K as of Q4 2024.
  • HBC Financial Services left its Bristol-Myers Squibb share count unchanged in Q4 2024.
  • Bristol-Myers Squibb made up ﹤0.01% of HBC Financial Services's portfolio in Q4 2024, its #158 holding.
  • HBC Financial Services first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 8 quarters since.
  • HBC Financial Services's Bristol-Myers Squibb position peaked at $49K in Q4 2020.
  • 2,493 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2024.

Based on HBC Financial Services's 13F filing for Q4 2024, filed 16 Jan 2025.